California Stem Cell Agency Awards the Stone Research Foundation $1.3M to Fight Osteoarthritis
February 01, 2022 15:19 ET
|
The Stone Research Foundation
SAN FRANCISCO, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Kevin R. Stone, MD, Orthopaedic Surgeon and Chairman of the Stone Research Foundation, and Mani Vessal, Ph.D., Sr. Director of Research and...
C3i Center Inc. Secures CAP Accreditation, Launches New Lab Spinoff
November 09, 2021 10:00 ET
|
Centre C3i Inc.
MONTRÉAL, Nov. 09, 2021 (GLOBE NEWSWIRE) -- C3i Center Inc. has strengthened our position as Canada’s leading one-stop contract development and manufacturing organization operating in the cell...
Global Stem Cell Technologies Market is projected to be worth US$ 21.03 Billion by 2031: Visiongain Research Inc
October 27, 2021 07:58 ET
|
Visiongain Ltd
Visiongain Published Global Stem Cell Technologies & Applications Market Report 2021-2031. Value Forecasts by Type (Allogenic, and Autologous), by Product (Adult Stem Cells, Human Embryonic Stem...
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2021 Financial Results
October 15, 2021 16:36 ET
|
Cryo-Cell International, Inc.
OLDSMAR, Fla., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store...
Mesenchymal Stem Cells Market Value Projected To Reach US$ 2,600.5 Million By 2027 Covering Pre and Post COVID-19 Market Analysis: Acumen Research and Consulting
May 19, 2021 11:34 ET
|
Acumen Research and Consulting
LOS ANGELES, May 19, 2021 (GLOBE NEWSWIRE) -- The Global Mesenchymal Stem Cells Market is expected to grow at a CAGR of around 7.1% from 2020 to 2027 and reach the market value of over US$ 2,600.5...
Sorrento Announces Updated Positive Results of Phase 1b Study of COVI-MSC™ for Treatment of ICU COVID-19 Patients
March 25, 2021 15:58 ET
|
Sorrento Therapeutics, Inc.
All nine patients with acute respiratory failure due to COVID-19 discharged from hospital within days after 3rd COVI-MSC infusionPreparations are ongoing for initiating Phase 2 placebo-controlled...
Bioreactors Market Trends 2021 | North America, Europe, & APAC Industry Forecasts 2026: Graphical Research
March 11, 2021 05:00 ET
|
Graphical Research
Pune, India, March 11, 2021 (GLOBE NEWSWIRE) -- The global bioreactors market is predicted to witness substantial growth rate during the forecast period. With the augmented demand for the...
Sorrento Announces Positive Preliminary Results of Phase 1b Study of COVI-MSC™ for Treatment of ICU COVID-19 Patients
January 26, 2021 19:09 ET
|
Sorrento Therapeutics, Inc.
First three patients discharged from Hospital ICU within 8 days from initial IV administration No infusion-related adverse events noted for any patient treated to date SAN DIEGO, Jan. 26, 2021 ...
IMAC Holdings to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference
January 05, 2021 09:00 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., Jan. 05, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative...
FibroGenesis Named Top 20 Most Innovative Companies of 2020 and Lands at the #2 Spot on Global Smart Leaders Magazine List
October 08, 2020 10:07 ET
|
FibroGenesis
HOUSTON, Oct. 08, 2020 (GLOBE NEWSWIRE) -- FibroGenesis, the leading developer of fibroblast based therapeutic solutions for unmet medical needs, is proud to announce Global Smart Leaders Magazine...